Article title: “Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery”
Authors: Saima Zameer, Javed Ali, Divya Vohora, Abul Kalam Najmi, and Mohd Akhtar
Journal: Journal of Drug Targeting
Bibliometrics: Volume 29, Number 2, pages 199–216
DOI: https://doi.org/10.1080/1061186X.2020.1817041
When the above article was published online and in print, the caption for Figure 16 is incorrect; the images in Figure 16(J) and Figure 16(L) are also incorrect. In addition, a typographical error on Table 5; the values of “N = 8” instead of “N = 5” in each group.
Below are the corrected version of caption for Figure 16; and the corrected versions of Figure 16(J) and Figure 16(L).
Figure 16. The figure is showing the Congo red staining for Aβ deposition in CA1 and CA3 region of mice hippocampus. The sections were examined at 4x; panel A – whole hippocampus, 10x; panel B and H – CA1 and CA3 region respectively and 40x; section C to G and I to M. Panel C and I. Control; D and J. Sham; E and K. STZ; F and L. STZ + CS-ALN-NPs; G and M. STZ + ALN soln. STZ: Streptozotocin; ALN: Alendronate; soln.: Solution; CS: Chitosan and NPs: Nanoparticles
Figure 16(J)
Figure 16(L)
This article is available both online and in print. The online version has been corrected.